Siga Technologies (SIGA) Cash & Current Investments (2010 - 2025)
Siga Technologies (SIGA) posted Cash & Current Investments of $155.0 million for Q4 2025, down 9.88% on a QoQ basis from $172.0 million in Q3 2025, and little changed year-over-year from $155.4 million in Q4 2024.
Siga Technologies (SIGA) Cash & Current Investments (2010 - 2025) Analysis & Trends
Siga Technologies' Cash & Current Investments history runs 16 years deep, the most recent figure standing at $155.0 million for Q4 2025.
- Quarterly Cash & Current Investments changed 0.28% year-over-year to $155.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $155.0 million (changed 0.28% YoY) and the FY2025 annual result came in at $155.0 million, changed 0.28% from the prior year.
- Cash & Current Investments was $155.0 million for Q4 2025 at Siga Technologies, down from $172.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $182.5 million in Q2 2025 and bottomed at $71.1 million in Q3 2023.
- A 5-year average of $123.4 million and a median of $112.1 million in 2022 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2021 — Cash & Current Investments soared 85.59% — and 2023, when it slumped 35.2%.
- Siga Technologies' Cash & Current Investments stood at $103.1 million in 2021, then declined by 4.22% to $98.8 million in 2022, then soared by 51.98% to $150.1 million in 2023, then increased by 3.5% to $155.4 million in 2024, then retreated by 0.28% to $155.0 million in 2025.
- Business Quant data shows SIGA's Cash & Current Investments at $155.0 million in Q4 2025, $172.0 million in Q3 2025, and $182.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Siga Technologies | 224.48 Mn | 69.52 Mn | - | 154.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 154.97 Mn |
| Sep 30, 2025 | 171.96 Mn |
| Jun 30, 2025 | 182.46 Mn |
| Mar 31, 2025 | 162.27 Mn |
| Dec 31, 2024 | 155.40 Mn |
| Sep 30, 2024 | 99.27 Mn |
| Jun 30, 2024 | 106.95 Mn |
| Mar 31, 2024 | 143.87 Mn |
| Dec 31, 2023 | 150.15 Mn |
| Sep 30, 2023 | 71.11 Mn |
| Jun 30, 2023 | 76.21 Mn |
| Mar 31, 2023 | 115.68 Mn |
| Dec 31, 2022 | 98.79 Mn |
| Sep 30, 2022 | 109.75 Mn |
| Jun 30, 2022 | 114.53 Mn |
| Mar 31, 2022 | 153.26 Mn |
| Dec 31, 2021 | 103.14 Mn |
| Sep 30, 2021 | 92.82 Mn |
| Jun 30, 2021 | 98.49 Mn |
| Mar 31, 2021 | 106.53 Mn |